Tag: 39M
Therini Bio Raises Additional $39M in Series A Financing
Therini Bio, Inc., a Sacramento, CA-based clinical-stage biotech firm creating fibrin-targeting immunotherapies for neurodegenerative ailments pushed by vascular…
Addionics Raises $39M in Series B Funding
Addionics, a London, UK-based battery know-how firm, raised $39M in Collection B funding. The spherical was led by…